Physician profile
Robert J Daher
NPI 1104148675
$4,005.95
in general payments reported to CMS, 2019-2025
22 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2021: $305 · 2022: $1,711 · 2023: $727 · 2024: $231 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,200.00 | 2022 | |
| Boston Scientific Corporation | $814.67 | 2019-2023 | |
| Saluda Medical Americas, INC. | $411.41 | 2024-2025 | Evoke |
| Smith+Nephew, INC. | $314.76 | 2019-2025 | Aetos Shoulder System, Bone Anchors With Arthroscopic Delivery System |
| Amgen INC. | $205.38 | 2023-2025 | Prolia, Evenity, Prolia |
| Nevro Corp. | $181.69 | 2023-2024 | Senza |
| Medtronic USA, INC. | $127.90 | 2019 | |
| Depuy Synthes Sales INC. | $126.55 | 2021-2024 | Monovisc, Orthovisc, Peak |
| Bioventus LLC | $90.09 | 2021-2025 | Gelsyn-3, Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $78.16 | 2021-2022 | |
| Fx Shoulder Solutions, INC | $70.29 | 2021 | |
| Ferring Pharmaceuticals INC. | $64.43 | 2024 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $52.34 | 2023 | Tapestry, Comprehensive Shoulder System |
| Zimvie INC. | $48.22 | 2023 | |
| Pacira Therapeutics, INC. | $46.99 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $42.44 | 2025 | |
| Polaris Technology Solutions LLC | $37.82 | 2023-2025 | |
| Vericel Corporation | $26.83 | 2025 | Maci |
| Globus Medical, INC. | $19.95 | 2025 | Senza |
| Kowa Pharmaceuticals America, INC. | $18.43 | 2022 | |
| Abbott Laboratories | $13.86 | 2019 | |
| Medartis INC. | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Daher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.